Omega Therapeutics (OMGA)
US Market

Omega Therapeutics (OMGA) Financial Statements


Omega Therapeutics Financial Overview

Omega Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.221; its P/E ratio is -0.97; Omega Therapeutics is scheduled to report earnings on March 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 759.00K$ 516.00K$ 734.00K$ 595.00K$ 476.00K
Gross Profit$ 378.00K$ 104.00K$ -205.00K--
EBIT$ -30.20M$ -26.38M$ -32.06M$ -25.98M$ -25.86M
EBITDA$ 0.00$ -25.02M$ -27.84M$ -25.59M$ -25.45M
Net Income Common Stockholders$ -29.69M$ -25.28M$ -30.83M$ -25.80M$ -25.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 112.98M$ 136.79M$ 124.68M$ 148.35M$ 173.66M
Total Assets$ 229.05M$ 156.31M$ 141.84M$ 170.06M$ 193.05M
Total Debt$ 118.63M$ 22.23M$ 22.53M$ 22.89M$ 23.38M
Net Debt$ 5.65M$ -114.55M$ -102.14M$ -125.46M$ -150.28M
Total Liabilities$ 133.11M$ 33.31M$ 145.95M$ 36.41M$ 35.66M
Stockholders Equity$ 95.92M$ 123.00M$ 105.97M$ 133.65M$ 157.38M
Cash Flow-
Free Cash Flow-$ -28.08M$ -24.51M$ -25.16M$ -26.70M
Operating Cash Flow-$ -28.08M$ -24.22M$ -24.84M$ -26.09M
Investing Cash Flow-$ 22.05M$ 17.65M$ 10.59M$ 11.27M
Financing Cash Flow-$ 39.99M$ 586.00K$ 4.00K$ 35.00K
Currency in USD

Omega Therapeutics Earnings and Revenue History

Omega Therapeutics Debt to Assets

Omega Therapeutics Cash Flow

Omega Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis